In Vitro Assessment of Conventional and Plant-derived Antifungal Agents against Candida Species Prevalence

Chinenye Nwankwo; Ijeoma Okolo; Anthonia Mba; Henrietta Uzoeto; Evangeline Udenweze; Francisca Okoli; Mandu Thompson; Ezinwanne Chukwu; Nnyeneime Bassey; Justina Ngwu; Ikemesit Peter

doi:10.51847/64mXiTGGOe

2023 Volume 13 Issue 1

In Vitro Assessment of Conventional and Plant-derived Antifungal Agents against Candida Species Prevalence

Chinenye Nwankwo^1,2, Ijeoma Okolo³, Anthonia Mba⁴, Henrietta Uzoeto^5,6, Evangeline Udenweze⁷, Francisca Okoli¹, Mandu Thompson³, Ezinwanne Chukwu⁶, Nnyeneime Bassey³, Justina Ngwu⁶, Ikemesit Peter⁸*

¹Department of Applied Microbiology and Brewing, Faculty of Bioscience, Nnamdi Azikiwe University, Awka, Anambra, P. M. B. 5025, Nigeria.

²Department of Antiretroviral Treatment, Federal Medical Centre, Onitsha, Anambra, P. M. B. 430213, Nigeria.

³Department of Applied Science, Faculty of Pure and Applied Science, Federal College of Dental Technology and Therapy, Trans Ekulu, P.M.B. 01473, Enugu, Nigeria.

⁴Department of Industrial Microbiology and Brewing, Faculty of Bioscience, Nnamdi Azikiwe University, Awka, Anambra, P. M. B. 5025, Nigeria.

⁵Department of Microbiology, Faculty of Pure and Applied Science, Federal College of Dental Technology and Therapy, Trans Ekulu, P.M.B. 01473, Enugu, Nigeria.

⁶Department of Dental Therapy, Faculty of Dental Health, Federal College of Dental Technology and Therapy, Trans-Ekulu, P.M.B. 01473, Enugu, Nigeria.

⁷Department of Industrial Microbiology and Brewery, Faculty of Bioscience, Nnamdi Azikiwe University, Awka, Anambra, P. M. B. 5025, Nigeria

⁸Department of Public Health, Faculty of Health Technology and Engineering, Federal College of Dental Technology and Therapy, Trans-Ekulu, P.M.B. 01473, Enugu, Nigeria.

References

[1] Seyoum E, Bitew A, Mihret A. Distribution of Candida albicans and nonalbicans Candida species isolated in different clinical samples and their in vitro antifungal susceptibility profile in Ethiopia. BMC Infect Dis. 2020;20(1):231-5.

[2] Yassin MT, Mostafa AA, Al‑Askar AA, Bdeer R. In vitro antifungal resistance profile of Candida strains isolated from Saudi women suffering from vulvovaginitis. Eur J Med Res. 2020;25(1):1-23.

[3] Zavalishina SY, Bakulina ED, Eremin MV, Kumantsova ES, Dorontsev AV, Petina ES. Functional changes in the human body in the model of acute respiratory infection. J Biochem Technol. 2021;1:12(1):22-6.

[4] Sharma M, Chakrabarti A. Candidiasis and Other Emerging Yeasts. Curr Fungal Infect Rep. 2023;17(1):15-24.

[5] Kumar S, Kumar A, Roudbary M, Mohammadi R, Černakova L, Rodrigues CF. Overview of the infections related to rare Candida species. Pathogens. 2022;11(9):1-45.

[6] Costa-de-Oliveira S, Rodrigues AG. Candida albicans Antifungal Resistance and Tolerance in Bloodstream Infections: The Triad Yeast-Host-Antifungal. Microorganisms. 2020;8(2):154-7.

[7] Neerja J, Aruna A, Paramjeet G. Significance of Candida culture in women with vulvovaginal symptoms. J Obstet Gynecol India. 2006;56(2):139-41.

[8] Bauters TG, Dhont MA, Temmerman MI, Nelis HJ. Prevalence of vulvovaginal candidiasis and susceptibility to fluconazole in women. Am J Obstet Gynecol. 2002;187(3):569-74.

[9] Ghasemi M, Javadnoori M, Cheraghian B, Abbaspoor Z. HIV+ women's reproductive and sexual health in Iran: studying samples referring to behavioral diseases counseling centers. J Adv Pharm Educ Res. 2021;11(3):150-6.

[10] Gonçalves B, Ferreira C, Alves CT, Henriques M, Azeredo J, Silva S. Vulvovaginal candidiasis: epidemiology, microbiology and risk factors. Crit Rev Microbiol. 2016;42(6):905-27.

[11] Milanda T, Fitri WN, Barliana MI, Chairunnisaa AY, Sugiarti L. Antifungal activities of Medinilla speciosa Blume fruit extracts against Candida albicans and Trichophyton rubrum. J Adv Pharm Educ Res. 2021;11(3):1-8.

[12] Hong N, Lei Y, Chen H, Chen X, Tsui KM, Hu D, et al. Genotyping and Drug Resistance Profile of Clinical Isolates of Candida albicans from Vulvovaginal Candidiasis in Eastern China. Mycopathologia. 2022;187(2-3):217-24.

[13] Sharifi M, Badiee P, Abastabar M, Morovati H, Haghani I, Noorbakhsh M, et al. A 3-year study of Candida infections among patients with malignancy: etiologic agents and antifungal susceptibility profile. Front Cell Infect Microbiol. 2023;13:1152-552.

[14] Uma Maheshwari SI, Sumana MN. Retrospective analysis on distribution and antifungal susceptibility profile of Candida in clinical samples: A study from Southern India. Front Public Health. 2023;11:1160-841.

[15] Kumar R, Singh G. Substituted Benzimidazoles as Antibacterial and Antifungal Agents: A review. Pharmacophore. 2022;13(2).

[16] Zavalishina SY, Bakulina ED, Eremin MV, Kumantsova ES, Dorontsev AV, Petina ES. Functional changes in the human body in the model of acute respiratory infection. J Biochem Technol. 2021;12(1):22-6.

[17] Orji JO, Nwankwo CE, Onwuliri EA, Oru CM, Okoye AU, Inyogu JC, et al. Comparative Analysis of Antifungal Effects of Home Made and Commercially Available Virgin Coconut Oil on Vulvovaginal Candida Species in Abakaliki. Int J Mod Pharm Res. 2021;5(4):01-03.

[18] Peter IU, Edemekong C, Balogun OM, Ikusika BA, Ngwu JN, Bassey NU, et al. Phytochemical Screening and Antibacterial Activity of Aqueous Extract of Costus afer Plant on Selected Multidrug-Resistant Bacteria. IOSR J Pharm Biol Sci. 2022;17(1):39-42.

[19] Ude IU, Moses IB, Okoronkwo C, Ovia K, Okafor C, Chukwunwejim CR, et al. Phytochemical properties and antimicrobial activity of Buchholzia coriacea and Psychotria microphylla leaf extracts on bacterial pathogens isolated from aquatic environments in Nigeria. J Med Plants Res, 2021;15(6):232-40.

[20] Sanguinetti M, Porta R, Sali M, La Sorda M, Pecorini G, Fadda G, et al. Evaluation of VITEK 2 and RapID yeast plus systems for yeast species identification: experience at a large clinical microbiology laboratory. J Clin Microbiol. 2007;45(4):1343-6.

[21] Nwankwo CE, Orji JO, Opara JK, Oru CM, Ugadu IO, Inyogu JC, et al. Antifungal Susceptibility Profile Of Genitourinary Candida species AMONG Women Attending a Tertiary Hospital In Abakaliki, Nigeria. IOSR J Pharm Biol Sci. 2021;16(1):01-04.

[22] Seck MC, Engo PE, Gueye PAT, Faye C, Mbow M, Diongue K, et al. Identification and antifungal susceptibility of Candida species isolated from vulvovaginal candidiasis in Dakar. J Yeast Fungal Res. 2023;14(1):1-7.

[23] Krishnasamy L, Krishnakumar S, Santharam P, Saikumar C. Isolation and identification of Candida species in patients with Vulvovaginal candidiasis. J Pure Appl Microbiol. 2018;12:2269-73.

[24] Amiri M, Eghbali T, Miladi R, Omidi D. Evaluation of Sexual Satisfaction in Pregnant Women with Vaginal Candidiasis. Entomol Appl Sci Lett. 2021;8(1):52-9.

[25] ElFeky DS, Gohar NM, El-Seidi EH, Ezzat MM, Hassan S, AboElew SH. Species identification and antifungal susceptibility pattern of Candida isolates in cases of vulvovaginal Candidiasis. Alexandria J Med. 2016;52(3):269-77.

[26] Bitew A, Abebaw Y. Vulvovaginal candidiasis: Species distribution of Candida and their antifungal susceptibility pattern. BMC Womens Health. 2018;18(1):94-8.